1. Patients with primary malignant melanoma or angiosarcoma diagnosed histopathologically

2. Patients with superficial skin lesions whose maximum diameter of the target lesion is 15 cm or less

3. Patients with lesions that are lying 6 cm or less from the skin surface to the deepest part of the tumor

4. Patients with lesions in the head, neck, chest, or extremities

5. Patients who do not have apparent abnormal hematological and biochemical values in the latest screening test within 28 days of registration

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma